Renaissance Technologies’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.12M | Buy |
|
|||||
|
2025
Q2 | $4.23M | Buy |
|
|||||
|
2025
Q1 | $735K | Sell |
|
|||||
|
2024
Q4 | $1.39M | Buy |
|
|||||
|
2024
Q3 | $1.2M | Sell |
|
|||||
|
2024
Q2 | $1.44M | Sell |
|
|||||
|
2024
Q1 | $2.69M | Sell |
|
|||||
|
2023
Q4 | $2.06M | Buy |
|
|||||
|
2023
Q3 | $1.2M | Sell |
|
|||||
|
2023
Q2 | $1.93M | Buy |
|
|||||
|
2023
Q1 | $1.28M | Sell |
|
|||||
|
2022
Q4 | $2.15M | Sell |
|
|||||
|
2022
Q3 | $2.62M | Buy |
|
|||||
|
2022
Q2 | $2.66M | Buy |
|
|||||
|
2022
Q1 | $2.39M | Buy |
|
|||||
|
2021
Q4 | $2.19M | Sell |
|
|||||
|
2021
Q3 | $4.55M | Sell |
|
|||||
|
2021
Q2 | $6.5M | Sell |
|
|||||
|
2021
Q1 | $11.2M | Sell |
|
|||||
|
2020
Q4 | $13.5M | Sell |
|
|||||
|
2020
Q3 | $15.3M | Sell |
|
|||||
|
2020
Q2 | $19.6M | Buy |
|
|||||
|
2020
Q1 | $16.9M | Buy |
|
|||||
|
2019
Q4 | $17.1M | Buy |
|
|||||
|
2019
Q3 | $11.3M | Buy |
|
|||||
|
2019
Q2 | $15.8M | Buy |
|
|||||
|
2019
Q1 | $13.9M | Sell |
|
|||||
|
2018
Q4 | $19.9M | Sell |
|
|||||
|
2018
Q3 | $28.1M | Buy |
|
|||||
|
2018
Q2 | $32.3M | Buy |
|
|||||
|
2018
Q1 | $27.3M | Buy |
|
|||||
|
2017
Q4 | $15.1M | Buy |
|
|||||
|
2017
Q3 | $9.77M | Buy |
|
|||||
|
2017
Q2 | $6.37M | Buy |
|
|||||
|
2017
Q1 | $4.05M | Buy |
|
|||||
|
2016
Q4 | $1M | Buy |
|